Carlos Hader

Dr. Carlos Hader is an accomplished professional with a rich educational background in oncology and experimental medicine.

He holds a Postdoctoral Fellow in Oncology from Harvard University, a Doctor of Philosophy in Experimental Medicine from McGill University, a Master's degree in Molecular Biology from Université de Montréal, and a Bachelor's degree in Biology from Lebanese University - Faculty of Sciences.

Currently, Dr. Hader serves as the Head of Solid Tumors, CDx, and Oncology Pipeline in Global Medical Affairs at AbbVie, showcasing his expertise in the field.

Prior to this, he held key positions at AbbVie and Novartis, including Senior Scientific Director, Medical Lead, and Director roles contributing significantly to the oncology landscape.

With a strong academic foundation and extensive experience in the pharmaceutical industry, Dr. Hader has established himself as a reputable figure in oncology and medical affairs.

His tenure as a Research Scientist at Yale University further illustrates his commitment to advancing scientific knowledge and innovation.